Amplitude Therapeutics and Lilly Partner on RNA Vaccines for Infectious Diseases
Amplitude Therapeutics and Lilly partner to develop trans-amplifying RNA vaccines for infectious diseases, combining taRNA technology with Lilly’s global capabilities.
Trans-amplifying RNA | 20/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy